IVM
12
1
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Health of Babies Born From IVF Versus IVM at 5 Years Old
In Vitro Maturation of Human Eggs
Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes
A Pilot Study to Determine the Feasibility, Acceptance, and Effectiveness of In-vitro Maturation in Patients Without IVF Coverage
Single vs. Group CAPA-IVM Culture of Cumulus-oocyte Complexes
Health of IVF Versus IVM Children (FM-BABIES)
Effect of GM-CSF on CAPA-IVM System Success Rates in PCOS
Amphiregulin Versus Non-Amphiregulin Supplementation to Maturation Culturing Medium in IVM.
IVM Survey Among Reproductive Medicine Specialists
Fresh Versus Freeze-only After CAPA IVM on PCOS Patients
Children Born From IVM-CAPA vs IVF or Natural Conception
IVM Versus IVF in High Antral Follicle Count Patients